Friday, June 12, 2026
πŸ‡ΊπŸ‡Έ FDA

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 163 of 1,261

  1. US 11788077

    Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome

    Precision BioSciences, Inc. Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  2. US 11787869

    Methods of using muscle targeting complexes to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy or a disease associated with muscle weakness

    Dyne Therapeutics, Inc. Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  3. US 11787867

    Anti-GITR antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  4. US 11787833

    Modified cyclic dinucleoside compounds as sting modulators

    Aligos Therapeutics, Inc. Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  5. US 11786479

    Nucleic acid nanocapsules for drug delivery and targeted gene knockdown

    UNIVERSITY OF CONNECTICUT Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  6. US 11787771

    Hydrazide containing nuclear transport modulators and uses thereof

    Karyopharm Therapeutics Inc. Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  7. US 11786635

    Extracellular matrix for treating pelvic floor disorders and skeletal muscle degeneration

    The Regents of the University of California Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  8. US 11786606

    Site-specific quantitation of drug conjugations

    REGENERON PHARMACEUTICALS, INC. Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  9. US 11786603

    Optimized transglutaminase site-specific antibody conjugation

    REGENERON PHARMACEUTICALS, INC. Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  10. US 11786602

    ASH1L degraders and methods of treatment therewith

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  11. US 11786601

    Pegylated capsule-degrading enzyme for the treatment of anthrax

    The Government of the United States of America, as represented by the Secretary of the Navy Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  12. US 11786598

    Lipid formulations for delivery of therapeutic agents

    ARBUTUS BIOPHARMA CORPORATION Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  13. US 11787800

    BRD9 degraders and uses thereof

    FOGHORN THERAPEUTICS INC. Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  14. US 11786560

    Immunoisolation device

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  15. US 11786554

    Optimized engineered nucleases having specificity for the human T cell receptor alpha constant region gene

    Precision BioSciences, Inc. Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  16. US 11786536

    Salts of potassium ATP channel openers and uses thereof

    ESSENTIALIS, INC. Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  17. US 11787839

    Targeting Ξ±2Ξ΄-1-bound glutamate receptors for treating diseases and disorders

    The Board of Regents of the University of Texas System Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  18. US 11787804

    Compositions and methods for modulating hair growth

    The Regents of the University of California Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  19. US 11786591

    Recombinant metapneumovirus F proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  20. US 11787778

    Bi-functional compounds and methods for targeted ubiquitination of androgen receptor

    Montelino Therapeutics Inc. Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  21. US 11786597

    Ionic liquids for transdermal drug delivery

    The Regents of the University of California Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  22. US 11786608

    Isoquinolinyl triazolone complexes

    Takeda Pharmaceutical Company Limited Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  23. US 11787762

    Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha

    Arcus Biosciences, Inc. Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

  24. US 11786464

    PH responsive block copolymer compositions and micelles that inhibit MCT 1 and related proteins

    The Board of Regents of the University of Texas System Β· Granted Oct 17, 2023 Β· Expires Oct 12, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.